Patents

War or Co-operation: Implications of COVID-19 Vaccine Patents

IP Regimes May Delay a Timely Delivery of New COVID-19 Vaccines

Patenting to Fight Pandemics: The Canadian Story

Impact of COVID-19 on Intellectual Property system in Canada

US Pharma Company, Gilead Sciences, Expands Access to COVID-19 Treatment- Experts Remain Skeptical of Long-Term Demands

What USMCA Ratification Means for IP in Canada

Packaging is Prime Area for Delivering on Green Innovation

Bill C-13 (Covid-19 Emergency Response Act) amendments to Patent Act

How much does a patent cost? And why

Are We There Yet? Pooling Together to Fight the COVID-19 Pandemic